je.st
news
Pacritinib Phase 3 Study Shows Positive Results In Patient Reported...
2015-06-12 11:30:00| Logistics - Topix.net
As recently reported at the American Society of Clinical Oncology annual meeting, results show a significant reduction in the Total Symptom Score , and in each individual common disease-related symptom, from baseline to Week 24, in patients treated with pacritinib compared to best available therapy . These PROs, as well as other quality of life measures, will be presented at the 20th Congress of European Hematology Association by .
Tags: results
study
shows
positive
Category:Transportation and Logistics